{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:13:39Z","timestamp":1770822819269,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clinical Liver Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1002\/cld.1231","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T07:50:45Z","timestamp":1658476245000},"page":"120-123","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Natural history and management of refractory autoimmune hepatitis"],"prefix":"10.1097","volume":"20","author":[{"given":"Bridget","family":"Whitehead","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition,Northwestern University,Feinberg School of Medicine,Ann & Robert H. Lurie Children's Hospital of Chicago,Chicago,Illinois,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0143-7450","authenticated-orcid":false,"given":"Alyssa","family":"Kriegermeier","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition,Northwestern University,Feinberg School of Medicine,Ann & Robert H. Lurie Children's Hospital of Chicago,Chicago,Illinois,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"cld1231-bib-0001-20241015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","year":"2020","journal-title":"Hepatology"},{"key":"cld1231-bib-0002-20241015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"cld1231-bib-0003-20241015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365520903555861","article-title":"Characteristics and long\u2010term outcome of patients with autoimmune hepatitis related to the initial treatment response","volume":"45","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"cld1231-bib-0004-20241015","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/apt.15157","article-title":"Systematic review with meta\u2010analysis: mycophenolate mofetil as a second\u2010line therapy for autoimmune hepatitis","volume":"49","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"cld1231-bib-0005-20241015","first-page":"1","article-title":"Management of difficult cases of autoimmune hepatitis","volume":"18","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"cld1231-bib-0006-20241015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MEG.0000000000001580","article-title":"Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real\u2010world\u2010experience","volume":"32","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"cld1231-bib-0007-20241015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MPG.0000000000001530","article-title":"Second\u2010line agents in pediatric patients with autoimmune hepatitis: a systematic review and meta\u2010analysis","volume":"65","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"cld1231-bib-0008-20241015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjmed.2014.06.016","article-title":"Use of sirolimus in the treatment of refractory autoimmune hepatitis","volume":"127","year":"2014","journal-title":"Am J Med"},{"key":"cld1231-bib-0009-20241015","first-page":"e4","article-title":"Sirolimus as rescue therapy in pediatric autoimmune hepatitis","volume":"58","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"cld1231-bib-0010-20241015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0039-1688751","article-title":"The contribution of B cells in autoimmune liver diseases","volume":"39","year":"2019","journal-title":"Semin Liver Dis"},{"key":"cld1231-bib-0011-20241015","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab","volume":"132","year":"2013","journal-title":"Pediatrics"},{"key":"cld1231-bib-0012-20241015","article-title":"Treatment of refractory pediatric autoimmune hepatitis with rituximab","volume":"2","year":"2021","journal-title":"JPGN Rep"},{"key":"cld1231-bib-0013-20241015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"cld1231-bib-0014-20241015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.humimm.2007.03.010","article-title":"Elevated serum BAFF levels in patients with autoimmune hepatitis","volume":"68","year":"2007","journal-title":"Hum Immunol"},{"key":"cld1231-bib-0015-20241015","article-title":"Belimumab is a promising third\u2010line treatment option for refractory autoimmune hepatitis","volume":"2","year":"2020","journal-title":"JHEP Rep"},{"key":"cld1231-bib-0016-20241015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2013.05.046","article-title":"Infliximab as rescue therapy in paediatric autoimmune hepatitis","volume":"59","year":"2013","journal-title":"J Hepatol"},{"key":"cld1231-bib-0017-20241015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult\u2010to\u2010treat autoimmune hepatitis","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"cld1231-bib-0018-20241015","article-title":"Characterization of auto\u2010immune hepatitis associated with the use of anti\u2010TNF\u03b1 agents: an analysis of 389 cases in VigiBase","volume":"19","year":"2020","journal-title":"Autoimmun Rev"},{"key":"cld1231-bib-0019-20241015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver injury from tumor necrosis factor\u2010\u03b1 antagonists: analysis of thirty\u2010four cases","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"cld1231-bib-0020-20241015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cgh.2017.11.003","article-title":"Budesonide in autoimmune hepatitis: the right drug at the right time for the right patient","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"cld1231-bib-0021-20241015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.mpg.0000304456.84552.13","article-title":"Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis","volume":"46","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"cld1231-bib-0022-20241015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1665-2681(19)31493-0","article-title":"Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis","volume":"11","year":"2012","journal-title":"Ann Hepatol"},{"key":"cld1231-bib-0023-20241015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real\u2010world experience and a comprehensive review","volume":"52","year":"2017","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cld.1231","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cld.1231","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/cld.1231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T22:02:00Z","timestamp":1729029720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/cld.1231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/cld.1231","relation":{},"ISSN":["2046-2484","2046-2484"],"issn-type":[{"value":"2046-2484","type":"print"},{"value":"2046-2484","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"2022-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}